| Item Type | Name |
|
Concept
|
Interleukin-1
|
|
Concept
|
Ribosomal Protein S6 Kinases, 90-kDa
|
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
|
Concept
|
Glycogen Synthase Kinase 3
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Membrane Proteins
|
|
Concept
|
Epithelial Cells
|
|
Concept
|
Transducin
|
|
Concept
|
Prognosis
|
|
Concept
|
Sequence Analysis, DNA
|
|
Concept
|
DNA-Binding Proteins
|
|
Concept
|
Transforming Growth Factor beta
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
Cyclin D1
|
|
Concept
|
Pancreas
|
|
Concept
|
Receptors, Androgen
|
|
Concept
|
Cell Movement
|
|
Concept
|
Multiple Myeloma
|
|
Concept
|
Down-Regulation
|
|
Concept
|
Tumor Suppressor Protein p53
|
|
Concept
|
Prostatic Neoplasms
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Mitogen-Activated Protein Kinases
|
|
Concept
|
PTEN Phosphohydrolase
|
|
Concept
|
Cell Nucleus
|
|
Concept
|
Ion Channels
|
|
Concept
|
Protein Kinase Inhibitors
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p21
|
|
Concept
|
Ribosomal Protein S6 Kinases, 70-kDa
|
|
Concept
|
Cell Cycle Proteins
|
|
Concept
|
Macrophages
|
|
Concept
|
MCF-7 Cells
|
|
Concept
|
Cell Cycle
|
|
Concept
|
Psychiatric Status Rating Scales
|
|
Concept
|
Cell Membrane
|
|
Concept
|
Receptor, Fibroblast Growth Factor, Type 3
|
|
Concept
|
ras Proteins
|
|
Concept
|
Analysis of Variance
|
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
|
Concept
|
Cell Culture Techniques
|
|
Concept
|
Response Elements
|
|
Concept
|
Class Ia Phosphatidylinositol 3-Kinase
|
|
Concept
|
Transduction, Genetic
|
|
Concept
|
Receptor, ErbB-2
|
|
Concept
|
Cell Transformation, Neoplastic
|
|
Concept
|
RNA Interference
|
|
Concept
|
Telomerase
|
|
Concept
|
Mitogen-Activated Protein Kinase Kinases
|
|
Concept
|
Cell Survival
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Cell Adhesion
|
|
Concept
|
Polymorphism, Single Nucleotide
|
|
Concept
|
Hydrogen Peroxide
|
|
Concept
|
Recombinant Proteins
|
|
Concept
|
Pancreatic Neoplasms
|
|
Concept
|
STAT6 Transcription Factor
|
|
Concept
|
Mice, SCID
|
|
Concept
|
Spectrometry, Fluorescence
|
|
Concept
|
Extracellular Signal-Regulated MAP Kinases
|
|
Concept
|
Neoplasm Staging
|
|
Concept
|
Proliferating Cell Nuclear Antigen
|
|
Concept
|
Proto-Oncogene Proteins p21(ras)
|
|
Concept
|
Drug Resistance, Neoplasm
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Carcinoma, Pancreatic Ductal
|
|
Concept
|
Cell Growth Processes
|
|
Concept
|
Tamoxifen
|
|
Concept
|
Cell Line
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
Guanosine Triphosphate
|
|
Concept
|
Indicators and Reagents
|
|
Concept
|
Tumor Cells, Cultured
|
|
Concept
|
Biopsy
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Prostate-Specific Antigen
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
Up-Regulation
|
|
Concept
|
Intracellular Signaling Peptides and Proteins
|
|
Concept
|
Sodium
|
|
Concept
|
Hyaluronoglucosaminidase
|
|
Concept
|
Proto-Oncogene Proteins c-met
|
|
Concept
|
Triple Negative Breast Neoplasms
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p27
|
|
Concept
|
Protein Conformation
|
|
Concept
|
Carcinogenesis
|
|
Concept
|
United States Food and Drug Administration
|
|
Concept
|
Gene Deletion
|
|
Concept
|
TOR Serine-Threonine Kinases
|
|
Concept
|
In Situ Hybridization, Fluorescence
|
|
Concept
|
NADPH Oxidases
|
|
Concept
|
Antimanic Agents
|
|
Concept
|
Proto-Oncogene Proteins
|
|
Concept
|
ErbB Receptors
|
|
Concept
|
Gene Knockout Techniques
|
|
Concept
|
Receptors, Estrogen
|
|
Concept
|
Carcinoma, Small Cell
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
Repressor Proteins
|
|
Concept
|
Genes, ras
|
|
Concept
|
Proto-Oncogene Proteins c-akt
|
|
Concept
|
Sequence Deletion
|
|
Concept
|
Multicenter Studies as Topic
|
|
Concept
|
Cells, Cultured
|
|
Concept
|
Class I Phosphatidylinositol 3-Kinases
|
|
Concept
|
Rod Cell Outer Segment
|
|
Concept
|
DNA Mutational Analysis
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
Guanosine Diphosphate
|
|
Concept
|
Estrogen Receptor alpha
|
|
Concept
|
Phosphorylation
|
|
Academic Article
|
Effect of chronic Li+ treatment on free intracellular Mg2+ in human neuroblastoma SH-SY5Y cells.
|
|
Academic Article
|
Evaluation of [Co(gly)3]- as a 35Cl- NMR shift reagent for cellular studies.
|
|
Academic Article
|
Testing competing path models linking the biochemical variables in red blood cells from Li+-treated bipolar patients.
|
|
Academic Article
|
Effects of Li(+) transport and Li(+) immobilization on Li(+)/Mg(2+) competition in cells: implications for bipolar disorder.
|
|
Academic Article
|
Competition between lithium and magnesium ions for the G-protein transducin in the guanosine 5'-diphosphate bound conformation.
|
|
Academic Article
|
Identification of Li(+) binding sites and the effect of Li(+) treatment on phospholipid composition in human neuroblastoma cells: a (7)Li and (31)P NMR study.
|
|
Academic Article
|
Physiologic estrogen receptor alpha signaling in non-tumorigenic human mammary epithelial cells.
|
|
Academic Article
|
Interleukin-1 alpha mediates the growth proliferative effects of transforming growth factor-beta in p21 null MCF-10A human mammary epithelial cells.
|
|
Academic Article
|
P21 gene knock down does not identify genetic effectors seen with gene knock out.
|
|
Academic Article
|
Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
|
|
Academic Article
|
The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.
|
|
Academic Article
|
A PCR-based high-throughput screen with multiround sample pooling: application to somatic cell gene targeting.
|
|
Academic Article
|
Tamoxifen-stimulated growth of breast cancer due to p21 loss.
|
|
Academic Article
|
P21 and p27: roles in carcinogenesis and drug resistance.
|
|
Academic Article
|
Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate.
|
|
Academic Article
|
Knockin of mutant PIK3CA activates multiple oncogenic pathways.
|
|
Academic Article
|
Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations.
|
|
Academic Article
|
PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells.
|
|
Academic Article
|
Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells.
|
|
Academic Article
|
The growth response to androgen receptor signaling in ERa-negative human breast cells is dependent on p21 and mediated by MAPK activation.
|
|
Academic Article
|
Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation.
|
|
Academic Article
|
MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers.
|
|
Academic Article
|
Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin.
|
|
Academic Article
|
Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer.
|
|
Academic Article
|
KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.
|
|
Academic Article
|
Somatic loss of PIK3R1 may sensitize breast cancer to inhibitors of the MAPK pathway.
|
|
Academic Article
|
Expression and function of voltage gated proton channels (Hv1) in MDA-MB-231 cells.
|
|
Academic Article
|
Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells.
|
|
Academic Article
|
FDA Approval Summary: Capmatinib and Tepotinib for the Treatment of Metastatic NSCLC Harboring MET Exon 14 Skipping Mutations or Alterations.
|
|
Concept
|
RAW 264.7 Cells
|
|
Concept
|
Trastuzumab
|
|
Concept
|
Glycogen Synthase Kinase 3 beta
|
|
Concept
|
Pre-B-Cell Leukemia Transcription Factor 1
|